Another gene therapy product has been added to the FDA-approved list: SKYSONA, a one-time gene therapy aimed to treat early,...
bluebird
The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
It seems that the hope of gene therapy for transfusion-dependent β-thalassemia (TDT) is becoming so close. During the 62nd American Society...
